Bruno Catalanotti

Naples, 80131, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Finding Balance: Multiobjective Optimization in Molecular Generative Modeling.

Finding Balance: Multiobjective Optimization in Molecular Generative Modeling.

Journal: Journal of chemical information and modeling

Published: June 19, 2026

Novel fatty acid amide hydrolase (FAAH) inhibitors: a patent review from 2015 to 2025.

Novel fatty acid amide hydrolase (FAAH) inhibitors: a patent review from 2015 to 2025.

Journal: Expert opinion on therapeutic patents

Published: January 21, 2026

Identification of the first peptide inhibitor of UBE2C enzymatic activity: insights from metadynamics-guided folding and binding studies.

Identification of the first peptide inhibitor of UBE2C enzymatic activity: insights from metadynamics-guided folding and binding studies.

Journal: Journal of enzyme inhibition and medicinal chemistry

Published: January 06, 2026

LIFR antagonism reverses epithelial pro-CAF programs in pancreatic ductal adenocarcinoma.

LIFR antagonism reverses epithelial pro-CAF programs in pancreatic ductal adenocarcinoma.

Journal: Biochemical pharmacology

Published: December 01, 2025

Harnessing the Estradienone Scaffold to Develop Dual GPBAR1 and LIFR Modulators for Liver Fibrosis.

Harnessing the Estradienone Scaffold to Develop Dual GPBAR1 and LIFR Modulators for Liver Fibrosis.

Journal: Journal of medicinal chemistry

Published: September 24, 2025

Repurposing FDA-approved drugs to target G-quadruplexes in breast cancer.

Repurposing FDA-approved drugs to target G-quadruplexes in breast cancer.

Journal: European journal of medicinal chemistry

Published: December 01, 2024

Design, Synthesis, and Pharmacological Evaluation of Dual FXR-LIFR Modulators for the Treatment of Liver Fibrosis.

Design, Synthesis, and Pharmacological Evaluation of Dual FXR-LIFR Modulators for the Treatment of Liver Fibrosis.

Journal: Journal of medicinal chemistry

Published: October 09, 2024

Microbial-derived bile acid reverses inflammation in IBD via GPBAR1 agonism and RORγt inverse agonism.

Microbial-derived bile acid reverses inflammation in IBD via GPBAR1 agonism and RORγt inverse agonism.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: September 20, 2024

Author Correction: Feedback inhibition of cAMP effector signaling by a chaperone-assisted ubiquitin system.

Author Correction: Feedback inhibition of cAMP effector signaling by a chaperone-assisted ubiquitin system.

Journal: Nature communications

Published: May 29, 2024

Synthesis, biological evaluation and metadynamics simulations of novel N-methyl β-sheet breaker peptides as inhibitors of Alzheimer's β-amyloid fibrillogenesis.

Synthesis, biological evaluation and metadynamics simulations of novel N-methyl β-sheet breaker peptides as inhibitors of Alzheimer's β-amyloid fibrillogenesis.

Journal: RSC medicinal chemistry

Published: January 22, 2024

Bile acids serve as endogenous antagonists of the Leukemia inhibitory factor (LIF) receptor in oncogenesis.

Bile acids serve as endogenous antagonists of the Leukemia inhibitory factor (LIF) receptor in oncogenesis.

Journal: Biochemical pharmacology

Published: December 04, 2023

The leukemia inhibitory factor regulates fibroblast growth factor receptor 4 transcription in gastric cancer.

The leukemia inhibitory factor regulates fibroblast growth factor receptor 4 transcription in gastric cancer.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: October 14, 2023

Showing 1-12 of 39

Last Updated: 09/26/2026